Toggle3D.AI Announces Board Member Changes

Rhea-AI Summary

Toggle3D.ai (OTCQB:TGGLF) announced changes to its Board of Directors. Board member Belinda Tyldesley has departed for personal reasons, and the company has appointed Peter Bloch as her replacement. Bloch brings extensive executive experience, including roles as CEO of BresoTEC Inc. and Bionik Laboratories. He is a CPA with a 25-year track record in building technology companies, particularly in life sciences.

Bloch's notable positions include CFO roles at Sanofi Canada, Intellivax Inc. (sold for $1.75B to GlaxoSmithKline), Tribute Pharmaceuticals, Gennum , and Just Energy. He has managed companies ranging from startups to $2B+ revenue enterprises and serves as an advisor to Mars Discovery District.

Positive

• Appointment of experienced executive Peter Bloch with significant public company management background
• New board member brings extensive financial expertise as CPA and former CFO of multiple billion-dollar companies
• Addition of director with proven track record in successful M&A transactions and IPO experience

Negative

• None.

TORONTO, ON / ACCESSWIRE / December 9, 2024 / Toggle3D.ai (the "Company") (OTCQB:TGGLF)(CSE:TGGL)(FSE:Q0C), a Nextech3d.ai (OTCQB:NEXCF)(CSE:NTAR) spinout is an innovative AI 3D platform harnessing the power of generative AI to convert CAD files, apply stunning 4K texturing, and seamlessly publish superior 4K 3D models announces the departure of Board member Belinda Tyldesley for personal reasons. We thank her for her service!

Toggle3d.ai also announced the appointment of Peter Bloch, a successful entrepreneur as new BOD member replacing Mrs. Tyldesley.

Bio:

Peter Bloch was the Chief Executive Officer of BresoTEC Inc. Mr. Bloch was also the CEO & Chairman of Bionik Laboratories from 2012 to 2018. Mr. Bloch is a CPA, CA, with a track record of building both public and private technology companies, mainly in the life sciences industry. In these roles, Mr. Bloch has secured significant funding for both private and public companies, gained experience with initial public offerings and led a number of acquisitions and partnership transactions. His past 25 years of executive management experience includes serving as Chief Financial Officer and joint interim CEO of Sanofi Canada Inc., the Canadian affiliate of Sanofi -Aventis, a global healthcare leader; Chief Financial Officer of Intellivax Inc., a biotechnology company which was sold to GlaxoSmithKline for $1.75 billion; founder of Tribute Pharmaceuticals, a specialty pharmaceutical company; the Chief Financial Officer of Gennum Corporation, a public semiconductor company focused on the TV and medical device market and Chief Financial Officer of Just Energy, a large public electricity and gas company . These companies have ranged in size from start-ups to companies with revenues of over $2 billion. Mr. Bloch also has substantial experience serving on the Board of Directors of both public and private companies. Mr. Bloch also serves as an advisor to Mars Discovery District, a large Canadian incubator for technology companies.

About Toggle3D.ai
Toggle3D.AI is a leading provider of innovative 3D rendering solutions, dedicated to transforming the way businesses visualize and present their products. Our platform harnesses the power of artificial intelligence to deliver high-quality, customizable images quickly and efficiently, helping e-commerce businesses thrive in a competitive market.

Toggle3D.ai Investor Relations

Visit the Toggle3D Investor Relations website and sign up for the investor mailing list to receive the latest news, press releases, investor presentations, CEO interviews, financial information and more.

Sign up for the investor mailing list - click here

Follow Toggle3D.ai on Social Media
Youtube: https://www.youtube.com/@Toggle3D
Insta: https://www.instagram.com/toggle3d.ai/
Facebook: https://www.facebook.com/Toggle3D
LinkedIn: https://www.linkedin.com/company/toggle3d-ai/
Twitter: https://twitter.com/Toggle3Dai

For further information, please contact:

Toggle3D.ai
Evan Gappelberg
Director
866-ARITIZE (274-8493)

Forward-looking Statements

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, "will be" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements regarding the completion of the transaction are subject to known and unknown risks, uncertainties and other factors. There can be no assurance that such statements will prove to be accurate, as future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Nextech will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

SOURCE: Toggle3D.AI Inc.

View the original press release on accesswire.com

FAQ

Who replaced Belinda Tyldesley on Toggle3D.ai (TGGLF) board of directors?

Peter Bloch, a successful entrepreneur and former CEO of BresoTEC Inc. and Bionik Laboratories, replaced Belinda Tyldesley who departed for personal reasons.

What is Peter Bloch's background joining Toggle3D.ai (TGGLF)?

Peter Bloch is a CPA with 25 years of executive management experience, including CEO and CFO roles at companies like Sanofi Canada, Intellivax, Tribute Pharmaceuticals, and Just Energy, managing businesses from startups to $2B+ in revenue.

What significant transaction experience does new Toggle3D.ai (TGGLF) board member Peter Bloch have?

Peter Bloch was involved in the sale of Intellivax Inc. to GlaxoSmithKline for $1.75 billion and has extensive experience with initial public offerings and partnership transactions.